Vaxserve Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 13 Days
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -4082.82%
- Ebitda -8219.42%
- Net Worth -766.79%
- Total Assets -79.66%
About Vaxserve Biotech
Vaxserve Biotech Private Limited (VBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 February 2021 (Four years 13 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Garg, Amit Garg, and Sambhav Gupta serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51507DL2021PTC376403
-
Company No.
376403
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Feb 2021
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vaxserve Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sambhav Gupta
|
Director | 02-Feb-2021 | Current |
|
Vishal Garg
|
Director | 02-Feb-2021 | Current |
|
Amit Garg
|
Director | 02-Feb-2021 | Current |
Financial Performance of Vaxserve Biotech.
Vaxserve Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 4082.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 766.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaxserve Biotech?
In 2021, Vaxserve Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Roshanara Club LimitedAmit Garg is a mutual person
-
Vaxserve LlpVishal Garg is a mutual person
-
Toasha Agencies Private Limited
Vishal Garg is a mutual person
-
Vaxserve Healthcare Private Limited
Vishal Garg and Amit Garg are mutual person
-
Toasha Vaccines Southend Private Limited
Amit Garg is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaxserve Biotech?
Vaxserve Biotech has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaxserve Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaxserve Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.